ISRG Rises 0.71% to $482.22 Following Strong Q1 Earnings Report

Market Performance Review of Intuitive Surgical, Inc. (ISRG) on April 24, 2026

Stock Performance Overview

On April 24, 2026, Intuitive Surgical, Inc. (ticker: ISRG) closed at a price of $482.22, reflecting an increase of $3.40 or 0.71% from the previous closing price of $478.82. The stock opened at $480.75, reached a high of $482.84, and a low of $471.00 during the trading session. The trading volume for the day was approximately 2.65 million shares, with a total market capitalization of approximately $170.78 billion.

Key Financial Metrics

• Opening Price: $480.75
• Closing Price: $482.22
• Daily High: $482.84
• Daily Low: $471.00
• Volume: 2.65 million shares
• Percentage Change: +0.71%

Recent News and Developments

1. Earnings Report Highlights:
   On April 21, 2026, Intuitive Surgical released its Q1 2026 earnings report, showcasing significant growth in both revenue and earnings per share (EPS). The company reported revenue of $2.77 billion, marking a 23% increase compared to $2.25 billion in Q1 2025. The GAAP EPS was $2.28, up from $1.92 the previous year, while the non-GAAP EPS reached $2.50, exceeding analysts' expectations.
2. Procedure Growth:
   The report highlighted robust growth in procedures utilizing the da Vinci and Ion surgical systems, with an overall increase of 17% year-over-year. Specifically, da Vinci procedures increased by 16%, while Ion procedures saw a remarkable growth of 39%. This surge in procedure volume indicates expanding adoption of robotic-assisted surgical technologies.
3. System Placements:
   In Q1 2026, the company placed 431 da Vinci surgical systems, up from 367 in Q1 2025, including 232 units of the latest da Vinci 5 systems. Additionally, 52 Ion endoluminal systems were placed, slightly higher than the 49 units placed in the same quarter last year.
4. Company Outlook:
   CEO Dave Rosa expressed optimism regarding the company’s future, emphasizing a commitment to enhancing patient outcomes and expanding access to care. For the remainder of 2026, Intuitive Surgical expects worldwide da Vinci procedure growth between 13.5% and 15.5%. The company anticipates a non-GAAP gross profit margin of 67.5% to 68.5% of revenue, despite a projected 1% impact from tariffs.
5. Market Sentiment:
   Analysts remain optimistic about Intuitive Surgical’s growth potential, particularly in light of the strong earnings report and increasing demand for robotic-assisted surgeries. However, concerns remain regarding possible tariff impacts and their effects on profit margins, which could introduce some volatility to the stock’s performance.
6. Analyst Ratings:
   Following the earnings report, several analysts reiterated positive outlooks on ISRG, with some suggesting the stock remains a strong buy given its growth trajectory and market position.

Conclusion

The market performance of Intuitive Surgical, Inc. on April 24, 2026, reflects a positive sentiment bolstered by strong earnings results and significant growth in surgical procedures. The company’s ability to expand market presence through increased system placements and a solid financial outlook positions it well for continued growth in upcoming quarters. Investors are advised to monitor ongoing developments, particularly regulatory changes or economic factors that may influence the company’s operational landscape.